首页> 外文期刊>Current therapeutic research, clinical and experimental. >Tolerability and Effectiveness of (S)-Amlodipine Compared With Racemic Amlodipine in Hypertension: A Systematic Review and Meta-Analysis
【24h】

Tolerability and Effectiveness of (S)-Amlodipine Compared With Racemic Amlodipine in Hypertension: A Systematic Review and Meta-Analysis

机译:(S)-氨氯地平与消旋氨氯地平在高血压中的耐受性和有效性:系统评价和荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Amlodipine is a calcium channel blocker prescribed for the management of angina and hypertension. As a racemic mixture, amlodipine contains (R)- and (S)-amlodipine isomers, but only (S)-amlodipine as the active moiety possesses therapeutic activity. Based on pharmacologic research, it remains uncertain if (S)-amlodipine alone has similar efficacy and fewer associated adverse events (AEs) compared with the racemic mixtures.OBJECTIVE: The aim of this systematic review and meta-analysis was to determine the effectiveness and tolerability of (S)-amlodipine compared with that of racemic amlodipine.
机译:背景:氨氯地平是一种用于治疗心绞痛和高血压的钙通道阻滞剂。作为消旋混合物,氨氯地平含有(R)-和(S)-氨氯地平异构体,但只有(S)-氨氯地平作为活性成分具有治疗活性。根据药理学研究,尚不确定与消旋混合物相比,仅(S)-氨氯地平是否具有相似的疗效和较少的相关不良事件(AE)。目的:进行系统评价和荟萃分析的目的是确定有效性和(S)-氨氯地平与消旋氨氯地平的耐受性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号